Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ECOSPOR IV: An Open-Label Extension of Study SERES-012 and Open-Label Program for Evaluating SER-109 in Subjects With Recurrent Clostridioides Difficile Infection (RCDI)

Next Previous
X
Search
Trial Profile

ECOSPOR IV: An Open-Label Extension of Study SERES-012 and Open-Label Program for Evaluating SER-109 in Subjects With Recurrent Clostridioides Difficile Infection (RCDI)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 23 Aug 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs SER 109 (Primary)
  • Indications Clostridium difficile infections
  • Focus Registrational; Therapeutic Use
  • Acronyms ECOSPOR IV
  • Sponsors Seres Therapeutics

    • Most Recent Events

    • 12 Oct 2023 According to a Seres Therapeutics media release, results from post-hoc analysis of the ECOSPOR III and ECOSPOR IV Phase 3 studies will be presented at ID Week 2023
    • 17 Jun 2023 According to a Seres Therapeutics media release, results from post-hoc analysis of the ECOSPOR III and ECOSPOR IV Phase 3 studies was featured as a late-breaker Emerging Science presentation at American Society of Microbiology (ASM) Microbe 2023
    • 17 Jun 2023 Results from post-hoc analysis of the ECOSPOR III and ECOSPOR IV Phase 3 studies presented in the Seres Therapeutics Media Release

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top